A survey of retail prices of antimicrobial products used in small-scale chicken farms in the Mekong Delta of Vietnam.


Journal

Globalization and health
ISSN: 1744-8603
Titre abrégé: Global Health
Pays: England
ID NLM: 101245734

Informations de publication

Date de publication:
14 01 2020
Historique:
received: 11 09 2019
accepted: 29 12 2019
entrez: 16 1 2020
pubmed: 16 1 2020
medline: 12 3 2020
Statut: epublish

Résumé

In the Mekong Delta region of Vietnam, high quantities of products containing antimicrobial are used as prophylactic and curative treatments in small-scale chicken flocks. A large number of these contain antimicrobial active ingredients (AAIs) considered of 'critical importance' for human medicine according to the World Health Organization (WHO). However, little is known about the retail prices of these products and variables associated with the expense on antimicrobials at farm level. Therefore, the aims of the study were: (1) to investigate the retail price of antimicrobials with regards to WHO importance criteria; and (2) to quantify the antimicrobial expense incurred in raising chicken flocks. We investigated 102 randomly-selected small-scale farms raising meat chickens (100-2000 per flock cycle) in two districts in Dong Thap (Mekong Delta) over 203 flock production cycles raised in these farms. Farmers were asked to record the retail prices and amounts of antimicrobial used. A total of 214 different antimicrobial-containing products were identified. These contained 37 different AAIs belonging to 13 classes. Over half (60.3%) products contained 1 highest priority, critically important AAI, and 38.8% 1 high priority, critically important AAI. The average (farm-adjusted) retail price of a daily dose administered to a 1 kg bird across products was 0.40 cents of 1 US$ (₵) (SE ± 0.05). The most expensive products were those that included at least one high priority, critically important AAI, as well as those purchased in one of the two study districts. Farmers spent on average of ₵3.91 (SE ± 0.01) on antimicrobials per bird over the production cycle. The expense on antimicrobials in weeks with disease and low mortality was greater than on weeks with disease and high mortality, suggesting that antimicrobial use had a beneficial impact on disease outcomes (χ The retail prices of antimicrobial products used in chicken production in Mekong Delta small-scale chicken farms are very low, and not related to their relevance for human medicine. Farmers, however, demonstrated a degree of sensitivity to prices of antimicrobial products. Therefore, revising pricing policies of antimicrobial products remains a potential option to curb the use of antimicrobials of critical importance in animal production.

Sections du résumé

BACKGROUND
In the Mekong Delta region of Vietnam, high quantities of products containing antimicrobial are used as prophylactic and curative treatments in small-scale chicken flocks. A large number of these contain antimicrobial active ingredients (AAIs) considered of 'critical importance' for human medicine according to the World Health Organization (WHO). However, little is known about the retail prices of these products and variables associated with the expense on antimicrobials at farm level. Therefore, the aims of the study were: (1) to investigate the retail price of antimicrobials with regards to WHO importance criteria; and (2) to quantify the antimicrobial expense incurred in raising chicken flocks. We investigated 102 randomly-selected small-scale farms raising meat chickens (100-2000 per flock cycle) in two districts in Dong Thap (Mekong Delta) over 203 flock production cycles raised in these farms. Farmers were asked to record the retail prices and amounts of antimicrobial used.
RESULTS
A total of 214 different antimicrobial-containing products were identified. These contained 37 different AAIs belonging to 13 classes. Over half (60.3%) products contained 1 highest priority, critically important AAI, and 38.8% 1 high priority, critically important AAI. The average (farm-adjusted) retail price of a daily dose administered to a 1 kg bird across products was 0.40 cents of 1 US$ (₵) (SE ± 0.05). The most expensive products were those that included at least one high priority, critically important AAI, as well as those purchased in one of the two study districts. Farmers spent on average of ₵3.91 (SE ± 0.01) on antimicrobials per bird over the production cycle. The expense on antimicrobials in weeks with disease and low mortality was greater than on weeks with disease and high mortality, suggesting that antimicrobial use had a beneficial impact on disease outcomes (χ
CONCLUSIONS AND RECOMMENDATION
The retail prices of antimicrobial products used in chicken production in Mekong Delta small-scale chicken farms are very low, and not related to their relevance for human medicine. Farmers, however, demonstrated a degree of sensitivity to prices of antimicrobial products. Therefore, revising pricing policies of antimicrobial products remains a potential option to curb the use of antimicrobials of critical importance in animal production.

Identifiants

pubmed: 31937338
doi: 10.1186/s12992-019-0539-x
pii: 10.1186/s12992-019-0539-x
pmc: PMC6961362
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8

Subventions

Organisme : Wellcome Trust
ID : 110085/Z/15/Z
Pays : United Kingdom

Références

BMC Public Health. 2013 Dec 10;13:1158
pubmed: 24325208
Antibiotics (Basel). 2018 Aug 15;7(3):null
pubmed: 30111750
Lancet. 2016 Jan 9;387(10014):188-98
pubmed: 26603919
Int J Antimicrob Agents. 2018 Dec;52(6):771-782
pubmed: 30312654
Global Health. 2013 Oct 16;9:48
pubmed: 24131666
J Antimicrob Chemother. 2015 Jul;70(7):2144-52
pubmed: 25755000
Int J Antimicrob Agents. 2019 Aug;54(2):269-270
pubmed: 31085299
Appl Environ Microbiol. 2016 Jun 13;82(13):3727-3735
pubmed: 27084016
Front Vet Sci. 2019 Jun 21;6:174
pubmed: 31294033
Front Vet Sci. 2019 Mar 25;6:84
pubmed: 30968033
J Rural Med. 2012;7(2):51-8
pubmed: 25650145
Prev Vet Med. 2019 Apr 1;165:15-22
pubmed: 30851923
Science. 2017 Sep 29;357(6358):1350-1352
pubmed: 28963240
PLoS Med. 2013;10(5):e1001429
pubmed: 23667342
Zoonoses Public Health. 2015 Apr;62 Suppl 1:70-8
pubmed: 25430661
Antibiotics (Basel). 2019 Oct 25;8(4):null
pubmed: 31731499
Front Microbiol. 2017 Jun 13;8:1062
pubmed: 28659887

Auteurs

Nguyen T T Dung (NTT)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam.
InterRisk program, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.

Bao D Truong (BD)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam.
Faculty of Animal Science and Veterinary Medicine, University of Agriculture and Forestry, Ho Chi Minh City, Vietnam.

Nguyen V Cuong (NV)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam.

Nguyen T B Van (NTB)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam.

Doan H Phu (DH)

Faculty of Animal Science and Veterinary Medicine, University of Agriculture and Forestry, Ho Chi Minh City, Vietnam.

Bach T Kiet (BT)

Sub Department of Animal Health and Production, Cao Lanh, Vietnam.

Chalalai Rueanghiran (C)

Department of Veterinary Public Health, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand.

Vo B Hien (VB)

Sub Department of Animal Health and Production, Cao Lanh, Vietnam.

Guy Thwaites (G)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK.

Jonathan Rushton (J)

Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.

Juan Carrique-Mas (J)

Wellcome Vietnam Africa Asia Program, Oxford University Clinical Research Unit, 764, Vo Van Kiet, District 5, Ho Chi Minh City, Vietnam. jcarrique-mas@oucru.org.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, Oxford University, Oxford, UK. jcarrique-mas@oucru.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH